Here's What Key Metrics Tell Us About Amerant Bancorp (AMTB) Q3 Earnings

Amerant Bancorp Inc. (AMTB) reported $101.8 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 1.3%. EPS of $0.27 for the same period compares to $0.64 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $99.39 million, representing a surprise of +2.43%. The company delivered an EPS surprise of +17.39%, with the consensus EPS estimate being $0.23.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Amerant Bancorp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net charge-offs / Average total loans held for investment: 1.9% compared to the 1.8% average estimate based on three analysts. Efficiency Ratio: 228.7% compared to the 70.6% average estimate based on three analysts. Net interest margin: 3.5% versus 3.5% estimated by three analysts on average. Average Balances - Total interest-earning assets: $9.23 billion versus the two-analyst average estimate of $9.30 billion. Total Non-Performing Loans: $114.93 million versus $113.21 million estimated by two analysts on average. Total Non-Performing Assets: $129.44 million versus the two-analyst average estimate of $122.21 million. Noninterest income: $20.80 million compared to the $18.04 million average estimate based on three analysts. Net interest income: $81 million versus the three-analyst average estimate of $81.35 million. View all Key Company Metrics for Amerant Bancorp here>>>Shares of Amerant Bancorp have returned -2.7% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amerant Bancorp Inc. (AMTB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks